<DOC>
	<DOCNO>NCT02198508</DOCNO>
	<brief_summary>Background : Three iron chelators available market differ toxicity organ specificity ; evidence standardize chelation protocol remain inconclusive , patient transfusion-dependent beta-thalassemia treat DFO infusion show significant difference limitation daily activity , physical activity , quality life treat oral chelator . With license DFP America , reasonable combine DFP DFX . Patients find two oral chelators acceptable one oral one injectable . This pilot study rate use DFP improve iron excretion profile deferasirox . Methods : The investigator enrol 13 beta-thalassemia patient China Medical University Children 's Hospital May 2009-October 2011 . Five refuse take part pharmacokinetics ; participate iron excretion study . Seven irregular bowel function unable collect feces screen period baseline data . Subjects randomly assign rotate undergo treatment ( informed consent ) : ( A ) single oral dose DFX 30 mg/kg daily , ( B ) single oral dose DFP 40 mg/kg twice day , ( C ) oral dos DFX DFP administer sequentially ( DFX 30 mg/kg/d , deferiprone 40 mg/kg/d deferiprone 40 mg/kg/d 7-hour interval ) . Three-day drug dosage follow four-day washout . Collections urine stool proceed 24 hour per day , analyze separately . Through venous catheter , serial blood sample ( 1 mL/each sample ) collect glass tube contain heparin anticoagulant Time 0 ( pre-dosing ) 0.5 , 1 , 1.5 , 2 , 2.5 , 3 , 3.5 , 4 , 4.5 , 6 , 7 , 8 , 10 , 12 24 hour dose ; plasma concentration DFP DFX measure .</brief_summary>
	<brief_title>Clinical Trial Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>beta-Thalassemia</mesh_term>
	<mesh_term>Deferiprone</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<criteria>18 year age old serum ferritin great 2000 ng/mL , serum creatinine within normal range measure laboratory platelet count exceed 140000/mm3 body weight least 40 Kg None history clinical significant gastrointestinal , hepatic , renal , endocrine , oncologic , infectious , pulmonary cardiovascular disease HIV positive , history immunologic hypersensitivity medication woman pregnant breast feed drug alcohol abuse patient show abnormal irregular bowel function ( define three bowel movement day le one bowel movement every day ) receive warfarin , digoxin , antiarrhythmic antiseizure medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>